4//SEC Filing
Laskow-Pooley David 4
Accession 0001144204-19-025605
CIK 0001094038other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 4:01 PM ET
Size
5.2 KB
Accession
0001144204-19-025605
Insider Transaction Report
Form 4
Laskow-Pooley David
Director
Transactions
- Award
Common Stock
2019-05-09+7,260→ 25,543 total
Footnotes (1)
- [F1]Represents the portion of the annual board retainer for each non-employee director payable in immediately vested, common stock under the Company's 2014 Omnibus Stock Ownership Plan, as amended and based on the closing price of $5.51 per share, on the day immediately preceding the date of the Company's 2019 annual meeting.
Documents
Issuer
Marker Therapeutics, Inc.
CIK 0001094038
Entity typeother
Related Parties
1- filerCIK 0001638533
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 4:01 PM ET
- Size
- 5.2 KB